MSH|^~\&|SendAppName^2.16.840.1.114222.TBD^ISO|Sending-Facility^2.16.840.1.114222.TBD^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20140630120030.1234-0500||ORU^R01^ORU_R01|MESSAGE CONTROL ID|D|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~RIBD_MMG_V1.1^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||RIBD_NMEN_TC_01^^^SendAppName&2.16.840.1.114222.nnnn&ISO^^^^^^||~^^^^^^S||19990301|F||2106-3^White^CDCREC|^^Atlanta^13^30033^^^^13121|||||||||||2186-5^Not Hispanic or Latino^CDCREC|||||||20171031OBR|1||Mening_NNDSS_TC_01^SendAppName^2.16.840.1.114222.nnnn^ISO|68991-9^Epidemiologic Information^LN|||20171102111655|||||||||||||||20171102111655|||F||||||10150^Meningococcal disease  (Neisseria meningitidis)^NNDOBX|1|ST|32624-9^Other Race Text^LN||multiracial||||||FOBX|2|CWE|78746-5^Country of Birth^LN||USA^UNITED STATES OF AMERICA^ISO3166_1||||||FOBX|3|CWE|77983-5^Country of Usual Residence^LN||USA^UNITED STATES OF AMERICA^ISO3166_1||||||FOBX|4|TS|11368-8^Date of Illness Onset^LN||20171020||||||FOBX|5|TS|77976-9^Illness End Date^LN||20171025||||||FOBX|6|SN|77977-7^Illness Duration^LN||^5|d^day [time]^UCUM|||||FOBX|7|CWE|77996-7^Pregnancy Status^LN||N^No^HL70136||||||FOBX|8|TS|77975-1^Diagnosis Date^LN||20171020||||||FOBX|9|CWE|77974-4^Hospitalized^LN||Y^Yes^HL70136||||||FOBX|10|TS|8656-1^Admission Date^LN||20171020||||||FOBX|11|TS|8649-6^Discharge Date^LN||20171025||||||FOBX|12|SN|78033-8^Duration of Hospital Stay in Days^LN||^6||||||FOBX|13|CWE|77978-5^Subject Died^LN||Y^Yes^HL70136||||||FOBX|14|ST|77993-4^State Case Identifier^LN||GA12345||||||FOBX|15|ST|77997-5^Legacy Case Identifier^LN||48432148S012014||||||FOBX|16|SN|77998-3^Age at Case Investigation^LN||^18|a^year [time]^UCUM|||||FOBX|17|CWE|77982-7^Case Disease Imported Code^LN||PHC244^Indigenous^CDCPHINVS||||||FOBX|18|CWE|77984-3^Country of Exposure^LN|1|USA^UNITED STATES OF AMERICA^ISO3166_1||||||FOBX|19|CWE|77985-0^State or Province of Exposure^LN|1|13^Georgia^FIPS5_2||||||FOBX|20|ST|77986-8^City of Exposure^LN|1|Atlanta||||||FOBX|21|ST|77987-6^County of Exposure^LN|1|Fulton||||||FOBX|22|CWE|77989-2^Transmission Mode^LN||461551000124100^Droplet transmission^SCT||||||FOBX|23|CWE|77990-0^Case Class Status Code^LN||410605003^Confirmed present^SCT||||||FOBX|24|CWE|77965-2^Immediate National Notifiable Condition^LN||N^No^HL70136||||||FOBX|25|CWE|77980-1^Case Outbreak Indicator^LN||Y^Yes^HL70136||||||FOBX|26|ST|77981-9^Case Outbreak Name^LN||Outbreak01||||||FOBX|27|ST|77969-4^Jurisdiction Code^LN||S01||||||FOBX|28|CWE|48766-0^Reporting Source Type Code^LN||1^Hospital^HL70406||||||FOBX|29|ST|52831-5^Reporting Source ZIP Code^LN||30322||||||FOBX|30|ST|74549-7^Person Reporting to CDC - Name^LN||Skywalker, Luke||||||FOBX|31|ST|74548-9^Person Reporting to CDC - Phone Number^LN||555-321-9876||||||FOBX|32|ST|74547-1^Person Reporting to CDC - Email^LN||lskywalker@gadoh.org||||||FOBX|33|DT|77979-3^Case Investigation Start Date^LN||20171021||||||FOBX|34|DT|77995-9^Date Reported^LN||20171021||||||FOBX|35|TS|77972-8^Earliest Date Reported to County^LN||20171021||||||FOBX|36|TS|77973-6^Earliest Date Reported to State^LN||20171021||||||FOBX|37|SN|77991-8^MMWR Week^LN||^41||||||FOBX|38|DT|77992-6^MMWR Year^LN||2017||||||FOBX|39|DT|77970-2^Date First Reported to PHD^LN||20171021||||||FOBX|40|CWE|77966-0^Reporting State^LN||13^Georgia^FIPS5_2||||||FOBX|41|CWE|77967-8^Reporting County^LN||13121^Fulton, GA^FIPS6_4||||||FOBX|42|CWE|77968-6^National Reporting Jurisdiction^LN||13^GA^FIPS5_2||||||FOBX|43|TX|77999-1^Comment^LN||National Nmen Case||||||FOBX|44|CWE|76437-3^Insurance^LN||5^PRIVATE HEALTH INSURANCE^PHDSCPT||||||FOBX|45|SN|3141-9^Weight^LN||^130|[lb_av]^pound [mass]^UCUM|||||FOBX|46|SN|3137-7^Height^LN||^65|[in_us]^inch [length]^UCUM|||||FOBX|47|CWE|INV298^Bacterial Infection Syndrome^PHINQUESTION||7180009^Meningitis^SCT~PHC921^Bacteremia without focus^CDCPHINVS~10001005^Bacterial Septicemia^SCT~396234004^Infective arthritis^SCT||||||FOBX|48|CWE|INV235^Did Underlying Condition(s) Exist^PHINQUESTION||Y^Yes^HL70136||||||FOBX|49|CWE|INV236^Underlying Condition(s)^PHINQUESTION|1|24743004^Complement deficiency disease^SCT||||||FOBX|50|CWE|INV662^Underlying Conditions Indicator^PHINQUESTION|1|Y^Yes^HL70136||||||FOBX|51|CWE|INV661^Pregnancy Status at the Time of First Positive Culture^PHINQUESTION||60001007^Not pregnant nor postpartum^SCT||||||FOBX|52|CWE|224311000^Attending Higher Education College^SCT||Y^Yes^HL70136||||||FOBX|53|CWE|64990-5^Grade in School^LN||OTH^other^NULLFL^^^^^^case goes to school part-time||||||FOBX|54|CWE|INV1091^College Living Situation^PHINQUESTION||PHC25^Dormitory^CDCPHINVS||||||FOBX|55|ST|INV1092^Name of College/University^PHINQUESTION||Emory University||||||FOBX|56|CWE|INV615^In Day Care^PHINQUESTION||N^No^HL70136||||||FOBX|57|CWE|INV1093^Secondary Case^PHINQUESTION||N^No^HL70136||||||FOBX|58|CWE|INV636^Long-term Care Resident^PHINQUESTION||N^No^HL70136||||||FOBX|59|CWE|INV109^Case Investigation Status Code^PHINQUESTION||29179001^Closed^SCT||||||FOBX|60|CWE|INV975^Recurrent Disease with Same Pathogen^PHINQUESTION||N^No^HL70136||||||FOBX|61|CWE|INV656^Case Report Form Status^PHINQUESTION||255594003^Complete^SCT||||||FOBX|62|CWE|STD107^Had Sex with a Male within the Past 12 Months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|63|CWE|STD108^Had Sex with a Female within the Past 12 Months^PHINQUESTION||NASK^Did not ask^NULLFL||||||FOBX|64|SN|INV605^Number of Male Sexual Partners^PHINQUESTION||^2||||||FOBX|65|CWE|55277-8^HIV Status^LN||165815009^HIV negative^SCT||||||FOBX|66|CWE|32911000^Homeless^SCT||N^No^HL70136||||||FOBX|67|CWE|56831-1^Signs and Symptoms^LN|1|25064002^Headache^SCT||||||FOBX|68|CWE|INV919^Signs and Symptoms Indicator^PHINQUESTION|1|Y^Yes^HL70136||||||FOBX|69|CWE|56831-1^Signs and Symptoms^LN|2|161882006^Stiff Neck^SCT^||||||FOBX|70|CWE|INV919^Signs and Symptoms Indicator^PHINQUESTION|2|Y^Yes^HL70136||||||FOBX|71|CWE|427429004^Eculizumab^SCT||N^No^HL70136||||||FOBX|72|SN|INV143^Illness Onset Age^PHINQUESTION||^18|a^year [time]^UCUM|||||FOBX|73|CWE|75617-1^Residence^LN||PHC25^College dormitory^CDCPHINVS||||||FOBX|74|CWE|INV927^Epi-Linked to a Laboratory Confirmed Case^PHINQUESTION||N^No^HL70136||||||FOBX|75|CWE|LAB630^Laboratory Testing Performed^PHINQUESTION||Y^Yes^HL70136||||||FOBX|76|CWE|INV164^Laboratory Confirmed^PHINQUESTION||Y^Yes^HL70136||||||FOBX|77|CWE|INV290^Test Type^PHINQUESTION|1|LAB695^Culture^PHINQUESTION||||||FOBX|78|CWE|LAB278^Organism Name^PHINQUESTION|1|17872004^Neisseria meningitidis^SCT||||||FOBX|79|CWE|66746-9^Specimen Type^LN|1|258450006^CSF^SCT||||||FOBX|80|TS|68963-8^Specimen Collection Date/Time^LN|1|20171020||||||FOBX|81|CWE|INV291^Test Result^PHINQUESTION|1|10828004^Positive^SCT||||||FOBX|82|CWE|INV705^Serogroup^PHINQUESTION|1|103480009^B^SCT||||||FOBX|83|CWE|LAB652^Serogroup Method^PHINQUESTION|1|9718006^PCR^SCT||||||FOBX|84|CWE|82771-7^Performing Laboratory Type^LN|1|PHC643^Public health laboratory (state or local)^CDCPHINVS||||||FOBX|85|ST|68994-3^Performing Laboratory Name^LN|1|Unknown||||||FOBX|86|ST|LAB650^Test Manufacturer^PHINQUESTION|1|Unknown||||||FOBX|87|CWE|82314-6^Specimen Sent to CDC^LN|1|Y^Yes^HL70136||||||FOBX|88|ST|INV978^Lab Accession Number^PHINQUESTION|1|18340129||||||FOBX|89|TS|85930-6^Date Specimen Sent to CDC^LN|1|20171030||||||FOBX|90|CWE|LAB222^Susceptibility Test^PHINQUESTION||Y^Yes^HL70136||||||FOBX|91|CWE|LABAST6^Antimicrobial Susceptibility Test Type^PHINQUESTION|1|18631^Azithromycin^RXNORM^||||||FOBX|92|CWE|LABAST8^Antimicrobial Susceptibility Test Interpretation^PHINQUESTION|1|I^Intermediate^HL70078||||||FOBX|93|CWE|LABAST15^Susceptibility Testing Performing Lab Type^PHINQUESTION|1|PHC412^CDC Lab^CDCPHINVS||||||FOBX|94|CWE|LABAST7^Antimicrobial Susceptibility Test Method^PHINQUESTION|1|PHC1618^Automated Testing Instrument^CDCPHINVS||||||FOBX|95|CWE|LABAST6^Antimicrobial Susceptibility Test Type^PHINQUESTION|2|2191^Ceftazidime^RXNORM||||||FOBX|96|CWE|LABAST8^Antimicrobial Susceptibility Test Interpretation^PHINQUESTION|2|R^Resistant^HL70078||||||FOBX|97|CWE|LABAST15^Susceptibility Testing Performing Lab Type^PHINQUESTION|2|PHC1317^Hospital Laboratory^CDCPHINVS||||||FOBX|98|CWE|LABAST7^Antimicrobial Susceptibility Test Method^PHINQUESTION|2|443968007^Whole Genome Sequencing^SCT||||||FOBX|99|CWE|VAC126^Did the Subject Ever Receive a Vaccine Against This Disease^PHINQUESTION||Y^Yes^HL70136||||||FOBX|100|DT|VAC142^Date of Last Dose Prior to Illness Onset^PHINQUESTION||20170620||||||FOBX|101|SN|82745-1^Vaccination Doses Prior to Onset^LN||^1||||||FOBX|102|CWE|VAC148^Vaccinated per ACIP Recommendations^PHINQUESTION||N^No^HL70136||||||FOBX|103|CWE|VAC149^Reason Not Vaccinated Per ACIP Recommendations^PHINQUESTION||PHC1311^Missed opportunity in medical setting^CDCPHINVS||||||FOBX|104|TX|VAC133^Vaccine History Comments^PHINQUESTION||Vaccine history comments test||||||FOBX|105|CWE|30956-7^Vaccine Type^LN|1|136^Meningococcal MCV4O (Menveo)^CVX||||||FOBX|106|ST|VAC155^Vaccine Name^PHINQUESTION|1|Menevo||||||FOBX|107|DT|30952-6^Vaccine Administered Date^LN|1|99999999||||||FOBX|108|ST|30959-1^Vaccine Lot Number^LN|1|U1234A||||||FOBX|109|DT|VAC109^Vaccine Expiration Date^PHINQUESTION|1|20191231||||||FOBX|110|SN|30973-2^Vaccine Dose Number^LN|1|^1||||||FOBX|111|CWE|30957-5^Vaccine Manufacturer^LN|1|SKB^GlaxoSmithKline^MVX||||||FOBX|112|ST|VAC153^National Drug Code (NDC)^PHINQUESTION|1|58160-0955-09||||||FOBX|113|ST|VAC102^Vaccination Record Identifier^PHINQUESTION|1|N93458PA2||||||FOBX|114|SN|VAC105^Age at Vaccination^PHINQUESTION|1|^18|a^year [time]^UCUM|||||FOBX|115|CWE|VAC147^Vaccine Event Information Source^PHINQUESTION|1|PHC1936^Immunization Information System^CDCPHINVS||||||FOBX|116|CWE|30956-7^Vaccine Type^LN|2|48^Hib (PRP-T)^CVX||||||FOBX|117|ST|VAC155^Vaccine Name^PHINQUESTION|2|Vaccine Name||||||FOBX|118|DT|30952-6^Vaccine Administered Date^LN|2|20010403||||||FOBX|119|ST|30959-1^Vaccine Lot Number^LN|2|1234UAT||||||FOBX|120|DT|VAC109^Vaccine Expiration Date^PHINQUESTION|2|20191203||||||FOBX|121|SN|30973-2^Vaccine Dose Number^LN|2|^10||||||FOBX|122|CWE|30957-5^Vaccine Manufacturer^LN|2|AVI^Aviron^MVX||||||FOBX|123|ST|VAC153^National Drug Code (NDC)^PHINQUESTION|2|8545-1023-19||||||FOBX|124|ST|VAC102^Vaccination Record Identifier^PHINQUESTION|2|234S2341||||||FOBX|125|SN|VAC105^Age at Vaccination^PHINQUESTION|2|^25|mo^month [time]^UCUM|||||FOBX|126|CWE|VAC147^Vaccine Event Information Source^PHINQUESTION|2|UNK^unknown^NULLFL||||||FOBX|127|ST|LAB143^VPD Lab Message Reference Laboratory^PHINQUESTION|1|2.16.840.1.114222.4.1.10100||||||FOBX|128|ST|LAB598^VPD Lab Message Patient Identifier^PHINQUESTION|1|Y009990xx^^^&2.16.840.1.114222.4.1.10100&ISO||||||FOBX|129|ST|LAB125^VPD Lab Message Specimen Identifier^PHINQUESTION|1|009990xx-01^^^&2.16.840.1.114222.4.1.10100&ISO||||||FOBX|130|ST|85658-3^Current Occupation^LN|1|student||||||FOBX|131|CE|85659-1^Current Occupation Standardized^LN|1|9070^Student - NIOSH/NCHS [9070]^CDCOCCUPATION2010||||||FOBX|132|ST|85078-4^Current Industry^LN|1|student||||||FOBX|133|CE|85657-5^Current Industry Standardized^LN|1|7870^Colleges and universities, including junior colleges [7870]^CDCINDUSTRY2010||||||F